Clinical translational study of corneal collagen lens implantation for refractive correction

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059873

Enrollment

Unknown

Registered

2022-05-13

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractive error

Interventions

Experiment group:Corneal collagen lens implantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Hyperopia greater than + 6.00DS; 2. Patients can fully understand the possible benefits and risks of the trial and voluntarily accept surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with corneal disorders; 2. Patients with glaucoma, fundus lesions, and severe dry eye disease; 3. Patients with serious systemic diseases.

Design outcomes

Primary

Measure	Time frame
Corrected visual acuity, UCVA;	—

Secondary

Measure	Time frame
Diopter;Best Corrected Visual Acuity, BCVA;Aberration;Incidence of adverse reactions;	—

Countries

China

Contacts

Public ContactShen Ye

The First Affiliated Hospital, College of Medicine, Zhejiang University

idrshen@zju.edu.cn+86 13605711083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026